ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug-Coated Balloon for Coronary Artery Disease Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-1E13410
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Drug Coated Balloon for Coronary Artery Disease Market Research Report 2023
BUY CHAPTERS

Global Drug-Coated Balloon for Coronary Artery Disease Market Research Report 2025

Code: QYRE-Auto-1E13410
Report
March 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
B. Braun
Yinyi
Eurocor GmbH
Biotronic

Drug-Coated Balloon for Coronary Artery Disease Market Size

The global market for Drug-Coated Balloon for Coronary Artery Disease was valued at US$ 583 million in the year 2024 and is projected to reach a revised size of US$ 1604 million by 2031, growing at a CAGR of 15.8% during the forecast period.

Drug-Coated Balloon for Coronary Artery Disease Market

Drug-Coated Balloon for Coronary Artery Disease Market

The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.
The Coronary Drug-Coated Balloon market is driven by the need for improved treatment options for coronary artery disease (CAD). These specialized balloons are designed to deliver drugs directly to the site of arterial blockages during angioplasty, preventing restenosis and promoting vessel healing. The rise in CAD cases and the demand for minimally invasive interventions contribute to market growth as patients and cardiologists seek solutions that reduce the need for repeat procedures. Moreover, advancements in drug formulation and balloon technology, including controlled drug release and enhanced drug adherence, align with better patient outcomes. However, the market also faces challenges, including addressing the potential for adverse reactions to the drug coating and ensuring precise drug delivery to the targeted area. Additionally, navigating regulatory approvals and conducting long-term efficacy studies can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and effective drug-coated balloon solutions, collaborate with interventional cardiologists for insights, and address the challenges to meet the increasing demand for advanced CAD treatment options.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug-Coated Balloon for Coronary Artery Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug-Coated Balloon for Coronary Artery Disease.
The Drug-Coated Balloon for Coronary Artery Disease market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug-Coated Balloon for Coronary Artery Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug-Coated Balloon for Coronary Artery Disease manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drug-Coated Balloon for Coronary Artery Disease Market Report

Report Metric Details
Report Name Drug-Coated Balloon for Coronary Artery Disease Market
Accounted market size in year US$ 583 million
Forecasted market size in 2031 US$ 1604 million
CAGR 15.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company B. Braun, Yinyi, Eurocor, Biotronic
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Drug-Coated Balloon for Coronary Artery Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Drug-Coated Balloon for Coronary Artery Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Drug-Coated Balloon for Coronary Artery Disease Market growing?

Ans: The Drug-Coated Balloon for Coronary Artery Disease Market witnessing a CAGR of 15.8% during the forecast period 2025-2031.

What is the Drug-Coated Balloon for Coronary Artery Disease Market size in 2031?

Ans: The Drug-Coated Balloon for Coronary Artery Disease Market size in 2031 will be US$ 1604 million.

Who are the main players in the Drug-Coated Balloon for Coronary Artery Disease Market report?

Ans: The main players in the Drug-Coated Balloon for Coronary Artery Disease Market are B. Braun, Yinyi, Eurocor, Biotronic

What are the Application segmentation covered in the Drug-Coated Balloon for Coronary Artery Disease Market report?

Ans: The Applications covered in the Drug-Coated Balloon for Coronary Artery Disease Market report are Hospitals, ASCs, Catheterization Laboratory

What are the Type segmentation covered in the Drug-Coated Balloon for Coronary Artery Disease Market report?

Ans: The Types covered in the Drug-Coated Balloon for Coronary Artery Disease Market report are Paclitaxel Coated, Other Coated

Recommended Reports

Coronary Stents & Balloons

PTCA & Coronary Balloons

Peripheral & Vascular Balloons

1 Drug-Coated Balloon for Coronary Artery Disease Market Overview
1.1 Product Definition
1.2 Drug-Coated Balloon for Coronary Artery Disease by Type
1.2.1 Global Drug-Coated Balloon for Coronary Artery Disease Market Value Comparison by Type (2024 VS 2031)
1.2.2 Paclitaxel Coated
1.2.3 Other Coated
1.3 Drug-Coated Balloon for Coronary Artery Disease by Application
1.3.1 Global Drug-Coated Balloon for Coronary Artery Disease Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 ASCs
1.3.4 Catheterization Laboratory
1.4 Global Drug-Coated Balloon for Coronary Artery Disease Market Size Estimates and Forecasts
1.4.1 Global Drug-Coated Balloon for Coronary Artery Disease Revenue 2020-2031
1.4.2 Global Drug-Coated Balloon for Coronary Artery Disease Sales 2020-2031
1.4.3 Global Drug-Coated Balloon for Coronary Artery Disease Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drug-Coated Balloon for Coronary Artery Disease Market Competition by Manufacturers
2.1 Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drug-Coated Balloon for Coronary Artery Disease Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drug-Coated Balloon for Coronary Artery Disease, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug-Coated Balloon for Coronary Artery Disease, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug-Coated Balloon for Coronary Artery Disease, Product Type & Application
2.7 Global Key Manufacturers of Drug-Coated Balloon for Coronary Artery Disease, Date of Enter into This Industry
2.8 Global Drug-Coated Balloon for Coronary Artery Disease Market Competitive Situation and Trends
2.8.1 Global Drug-Coated Balloon for Coronary Artery Disease Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drug-Coated Balloon for Coronary Artery Disease Players Market Share by Revenue
2.8.3 Global Drug-Coated Balloon for Coronary Artery Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug-Coated Balloon for Coronary Artery Disease Market Scenario by Region
3.1 Global Drug-Coated Balloon for Coronary Artery Disease Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drug-Coated Balloon for Coronary Artery Disease Sales by Region: 2020-2031
3.2.1 Global Drug-Coated Balloon for Coronary Artery Disease Sales by Region: 2020-2025
3.2.2 Global Drug-Coated Balloon for Coronary Artery Disease Sales by Region: 2026-2031
3.3 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Region: 2020-2031
3.3.1 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Region: 2020-2025
3.3.2 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Region: 2026-2031
3.4 North America Drug-Coated Balloon for Coronary Artery Disease Market Facts & Figures by Country
3.4.1 North America Drug-Coated Balloon for Coronary Artery Disease Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2020-2031)
3.4.3 North America Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug-Coated Balloon for Coronary Artery Disease Market Facts & Figures by Country
3.5.1 Europe Drug-Coated Balloon for Coronary Artery Disease Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2020-2031)
3.5.3 Europe Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Market Facts & Figures by Region
3.6.1 Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Sales by Region (2020-2031)
3.6.3 Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drug-Coated Balloon for Coronary Artery Disease Market Facts & Figures by Country
3.7.1 Latin America Drug-Coated Balloon for Coronary Artery Disease Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2020-2031)
3.7.3 Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2020-2031)
4.1.1 Global Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2020-2025)
4.1.2 Global Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2026-2031)
4.1.3 Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Type (2020-2031)
4.2 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2020-2031)
4.2.1 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2020-2025)
4.2.2 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2026-2031)
4.2.3 Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Type (2020-2031)
4.3 Global Drug-Coated Balloon for Coronary Artery Disease Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2020-2031)
5.1.1 Global Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2020-2025)
5.1.2 Global Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2026-2031)
5.1.3 Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Application (2020-2031)
5.2 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2020-2031)
5.2.1 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2020-2025)
5.2.2 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2026-2031)
5.2.3 Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Application (2020-2031)
5.3 Global Drug-Coated Balloon for Coronary Artery Disease Price by Application (2020-2031)
6 Key Companies Profiled
6.1 B. Braun
6.1.1 B. Braun Company Information
6.1.2 B. Braun Description and Business Overview
6.1.3 B. Braun Drug-Coated Balloon for Coronary Artery Disease Sales, Revenue and Gross Margin (2020-2025)
6.1.4 B. Braun Drug-Coated Balloon for Coronary Artery Disease Product Portfolio
6.1.5 B. Braun Recent Developments/Updates
6.2 Yinyi
6.2.1 Yinyi Company Information
6.2.2 Yinyi Description and Business Overview
6.2.3 Yinyi Drug-Coated Balloon for Coronary Artery Disease Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Yinyi Drug-Coated Balloon for Coronary Artery Disease Product Portfolio
6.2.5 Yinyi Recent Developments/Updates
6.3 Eurocor
6.3.1 Eurocor Company Information
6.3.2 Eurocor Description and Business Overview
6.3.3 Eurocor Drug-Coated Balloon for Coronary Artery Disease Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eurocor Drug-Coated Balloon for Coronary Artery Disease Product Portfolio
6.3.5 Eurocor Recent Developments/Updates
6.4 Biotronic
6.4.1 Biotronic Company Information
6.4.2 Biotronic Description and Business Overview
6.4.3 Biotronic Drug-Coated Balloon for Coronary Artery Disease Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biotronic Drug-Coated Balloon for Coronary Artery Disease Product Portfolio
6.4.5 Biotronic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug-Coated Balloon for Coronary Artery Disease Industry Chain Analysis
7.2 Drug-Coated Balloon for Coronary Artery Disease Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug-Coated Balloon for Coronary Artery Disease Production Mode & Process Analysis
7.4 Drug-Coated Balloon for Coronary Artery Disease Sales and Marketing
7.4.1 Drug-Coated Balloon for Coronary Artery Disease Sales Channels
7.4.2 Drug-Coated Balloon for Coronary Artery Disease Distributors
7.5 Drug-Coated Balloon for Coronary Artery Disease Customer Analysis
8 Drug-Coated Balloon for Coronary Artery Disease Market Dynamics
8.1 Drug-Coated Balloon for Coronary Artery Disease Industry Trends
8.2 Drug-Coated Balloon for Coronary Artery Disease Market Drivers
8.3 Drug-Coated Balloon for Coronary Artery Disease Market Challenges
8.4 Drug-Coated Balloon for Coronary Artery Disease Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
B. Braun
Yinyi
Eurocor GmbH
Biotronic
List of Tables
 Table 1. Global Drug-Coated Balloon for Coronary Artery Disease Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Drug-Coated Balloon for Coronary Artery Disease Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Drug-Coated Balloon for Coronary Artery Disease Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Drug-Coated Balloon for Coronary Artery Disease Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Drug-Coated Balloon for Coronary Artery Disease Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Drug-Coated Balloon for Coronary Artery Disease Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Drug-Coated Balloon for Coronary Artery Disease, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Drug-Coated Balloon for Coronary Artery Disease, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Drug-Coated Balloon for Coronary Artery Disease, Product Type & Application
 Table 12. Global Key Manufacturers of Drug-Coated Balloon for Coronary Artery Disease, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drug-Coated Balloon for Coronary Artery Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Coated Balloon for Coronary Artery Disease as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drug-Coated Balloon for Coronary Artery Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Drug-Coated Balloon for Coronary Artery Disease Sales by Region (2020-2025) & (K Units)
 Table 18. Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Region (2020-2025)
 Table 19. Global Drug-Coated Balloon for Coronary Artery Disease Sales by Region (2026-2031) & (K Units)
 Table 20. Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Region (2026-2031)
 Table 21. Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Region (2020-2025)
 Table 23. Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Region (2026-2031)
 Table 25. North America Drug-Coated Balloon for Coronary Artery Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2020-2025) & (K Units)
 Table 27. North America Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2026-2031) & (K Units)
 Table 28. North America Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Drug-Coated Balloon for Coronary Artery Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Drug-Coated Balloon for Coronary Artery Disease Sales (K Units) by Type (2020-2025)
 Table 51. Global Drug-Coated Balloon for Coronary Artery Disease Sales (K Units) by Type (2026-2031)
 Table 52. Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Type (2020-2025)
 Table 53. Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Type (2026-2031)
 Table 54. Global Drug-Coated Balloon for Coronary Artery Disease Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Drug-Coated Balloon for Coronary Artery Disease Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Type (2020-2025)
 Table 57. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Type (2026-2031)
 Table 58. Global Drug-Coated Balloon for Coronary Artery Disease Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Drug-Coated Balloon for Coronary Artery Disease Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Drug-Coated Balloon for Coronary Artery Disease Sales (K Units) by Application (2020-2025)
 Table 61. Global Drug-Coated Balloon for Coronary Artery Disease Sales (K Units) by Application (2026-2031)
 Table 62. Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Application (2020-2025)
 Table 63. Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Application (2026-2031)
 Table 64. Global Drug-Coated Balloon for Coronary Artery Disease Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Drug-Coated Balloon for Coronary Artery Disease Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Application (2020-2025)
 Table 67. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Application (2026-2031)
 Table 68. Global Drug-Coated Balloon for Coronary Artery Disease Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Drug-Coated Balloon for Coronary Artery Disease Price (US$/Unit) by Application (2026-2031)
 Table 70. B. Braun Company Information
 Table 71. B. Braun Description and Business Overview
 Table 72. B. Braun Drug-Coated Balloon for Coronary Artery Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. B. Braun Drug-Coated Balloon for Coronary Artery Disease Product
 Table 74. B. Braun Recent Developments/Updates
 Table 75. Yinyi Company Information
 Table 76. Yinyi Description and Business Overview
 Table 77. Yinyi Drug-Coated Balloon for Coronary Artery Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Yinyi Drug-Coated Balloon for Coronary Artery Disease Product
 Table 79. Yinyi Recent Developments/Updates
 Table 80. Eurocor Company Information
 Table 81. Eurocor Description and Business Overview
 Table 82. Eurocor Drug-Coated Balloon for Coronary Artery Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Eurocor Drug-Coated Balloon for Coronary Artery Disease Product
 Table 84. Eurocor Recent Developments/Updates
 Table 85. Biotronic Company Information
 Table 86. Biotronic Description and Business Overview
 Table 87. Biotronic Drug-Coated Balloon for Coronary Artery Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Biotronic Drug-Coated Balloon for Coronary Artery Disease Product
 Table 89. Biotronic Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Drug-Coated Balloon for Coronary Artery Disease Distributors List
 Table 93. Drug-Coated Balloon for Coronary Artery Disease Customers List
 Table 94. Drug-Coated Balloon for Coronary Artery Disease Market Trends
 Table 95. Drug-Coated Balloon for Coronary Artery Disease Market Drivers
 Table 96. Drug-Coated Balloon for Coronary Artery Disease Market Challenges
 Table 97. Drug-Coated Balloon for Coronary Artery Disease Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drug-Coated Balloon for Coronary Artery Disease
 Figure 2. Global Drug-Coated Balloon for Coronary Artery Disease Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drug-Coated Balloon for Coronary Artery Disease Market Share by Type: 2024 & 2031
 Figure 4. Paclitaxel Coated Product Picture
 Figure 5. Other Coated Product Picture
 Figure 6. Global Drug-Coated Balloon for Coronary Artery Disease Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Drug-Coated Balloon for Coronary Artery Disease Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. ASCs
 Figure 10. Catheterization Laboratory
 Figure 11. Global Drug-Coated Balloon for Coronary Artery Disease Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Drug-Coated Balloon for Coronary Artery Disease Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Drug-Coated Balloon for Coronary Artery Disease Sales (2020-2031) & (K Units)
 Figure 14. Global Drug-Coated Balloon for Coronary Artery Disease Average Price (US$/Unit) & (2020-2031)
 Figure 15. Drug-Coated Balloon for Coronary Artery Disease Report Years Considered
 Figure 16. Drug-Coated Balloon for Coronary Artery Disease Sales Share by Manufacturers in 2024
 Figure 17. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Drug-Coated Balloon for Coronary Artery Disease Players: Market Share by Revenue in Drug-Coated Balloon for Coronary Artery Disease in 2024
 Figure 19. Drug-Coated Balloon for Coronary Artery Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Drug-Coated Balloon for Coronary Artery Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Country (2020-2031)
 Figure 22. North America Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Country (2020-2031)
 Figure 23. United States Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Country (2020-2031)
 Figure 26. Europe Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Region (2020-2031)
 Figure 34. China Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Drug-Coated Balloon for Coronary Artery Disease Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Drug-Coated Balloon for Coronary Artery Disease by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Drug-Coated Balloon for Coronary Artery Disease by Type (2020-2031)
 Figure 55. Global Drug-Coated Balloon for Coronary Artery Disease Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Drug-Coated Balloon for Coronary Artery Disease by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Drug-Coated Balloon for Coronary Artery Disease by Application (2020-2031)
 Figure 58. Global Drug-Coated Balloon for Coronary Artery Disease Price (US$/Unit) by Application (2020-2031)
 Figure 59. Drug-Coated Balloon for Coronary Artery Disease Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Coronary Drug Coated Balloon Market Research Report 2025
Global Drug Eluting Balloon for Coronary Artery Disease Market Research Report 2025
Global Drug Coated Balloon for Peripheral Artery Diseases Market Research Report 2025
Global PTA Drug Coated Balloons Market Research Report 2025
Global Drug Eluting Balloons DEB Market Insights Forecast to 2030
Global PTA Drug Eluting Balloons Market Research Report 2025
Global Paclitaxel Coated Balloon Catheter Market Research Report 2024
Global Drug Coated Coronary Balloon Catheter Market Research Report 2024
Paclitaxel Drug Eluting Balloon Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Implantable Drug Eluting Balloon Market Research Report 2024
Global Drug Coated Coronary Balloon Dilatation Catheter Market Research Report 2024
Global Peripheral Drug Coated Balloon Market Research Report 2024
Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon DEB Catheters Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peripheral Drug Coated Balloons DCBs Market Research Report 2024
Global Paclitaxel Coated PTA Balloon Catheter Market Research Report 2025
Global Paclitaxel Coated PTCA Balloon Catheter Market Research Report 2025
Global Drug Eluting Balloon for Peripheral Artery Disease Market Research Report 2024
Global Drug Eluting Coronary Stent Market Research Report 2025
Global Drug Eluting Coronary Stent System Market Research Report 2024
Global Coronary Drug Stent System Market Research Report 2024

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions